期刊文献+

患者总体评价在中轴型脊柱关节炎患者病情活动性评估中的意义 被引量:3

Value of patient global assessment on evaluating disease activity in patients with axial spondyloarthritis
原文传递
导出
摘要 目的探讨患者总体评价(PGA)在中轴型脊柱关节炎(SpA)患者病情活动性评估中的意义。方法收集222例中轴型SpA患者,分别计算PGA、疾病活动性评分[Bath AS病情活动指标(BASDAI)和基于C反应蛋白计算的强直性脊柱炎疾病活动评价积分(ASDAScrp)]和骶髂关节磁共振扫描下骨髓水肿(SPARCC)积分,比较不同疾病活动度组间PGA的水平,分析PGA与各疾病活动性指标间的相关性。采用SPSS 17.0软件进行统计分析,不同组间率的比较采用χ2检验,不同组间非正态分布计量资料的比较采用秩和检验,两两指标间相关性采用线性相关分析,采用ROC曲线计算PGA对判断中轴型SpA患者病情活动的截点值。结果① BASDAI缓解组PGA中位数[3(1,4)与5(4,7)]和ASDAScrp缓解组PGA中位数[1(1,2)与4(2,5)]明显低于活动组(P均〈0.01)。②BASDAI水平[1.80(1.20,2.90)与3.40(2.28,4.63)与5.15(4.08,5.88)]和ASDAScrp水平[2.19(1.34,2.76)与2.86(2.08,3.54)与4.08(2.96,4.41)]在PGA低度组(≤3)、中度组(4~6)和高度组(≥7)间差异有统计学意义(P均〈0.01);SPARCC积分在PGA低度组[6.00(0,18.00)]、中度组[7.50(3.75,18.00)]和高度组[18.50(6.75,24.50)]间差异有统计学意义(Z=7.427,P=0.037);ESR[12.00(5.00,23.00)mm/1 h,19.50(7.00,44.50)mm/1 h,18.00(7.75,54.75)mm/1 h]、CRP[7.85(2.37,22.49)mg/L,10.07(3.02,28.51)mg/L,21.28(7.14,37.74)mg/L]和BASFI[0.70(0.10,1.30),2.25(0.60,3.30),2.85(0.83,6.53)]等功能指标在PGA低度组、中度组和高度差异有统计学意义(P均〈0.01)。③ BASDAI病情活动组患者在PGA低度组、中度组和高度组所占比例差异有统计学意义(χ2=54.895,P〈0.01),且两者间呈正相关(r=0.497,P〈0.01);ASDAScrp高度以上病情活动组中在PGA低度组、中度组和高度组间所占比例� ObjectiveTo explore the value of patient global assessment (PGA) on evaluating disease activity in patients with axial spondyloarthritis (SpA).MethodsA total of 222 patients with axial SpA were recruited. Scores of PGA, disease activity index [Bath ankylosing spondylitis disease activity index (BASDAI), ankylosing spondylitis disease activity score (ASDAS)crp] and spondyloarthritis research consortium of Canada (SPARCC) were calculated. Differences of PGA scores between different disease activity groups in axial SpA were compared and correlations between different disease activity index with PGA scores were analyzed. Statistical analyses were performed using Statistical Product and Service Solutions (SPSS) software (version 17.0). Comparison of frequency among different groups was performed by χ2 test. Rank-sum test was used to compare the median of measurement data in different groups when the data were skewed in distribution. Cut-off value of PGA for assessing disease activity in axial SpA was calculated by ROC curve.ResultsMedians of PGA score in groups with BASDAI remission[3(1,4) vs 5(4,7)] and ASDAScrp remission [1(1,2) vs 4(2,5)] were lower than that in disease activity group (P〈0.01). BASDAI scores [1.80(1.20, 2.90) vs 3.40(2.28, 4.63) vs 5.15(4.08, 5.88)] and ASDAScrp scores [2.19(1.34, 2.76) vs 2.86(2.08, 3.54) vs 4.08(2.96, 4.41)] were significant different among PGA groups (≤3, 4-6 and ≥7) (P〈0.01). Differences of SPARCC scores [6.00(0, 18.00) vs 7.50(3.75, 18.00) vs 18.50(6.75, 24.50)] were statistically significant among PGA groups (Z=7.427, P=0.037). Erythrocyte sedimentation rate (ESR) [12.00(5.00, 23.00) mm/1 h vs 19.50(7.00, 44.50) mm/1 h vs 18.00(7.75, 54.75) mm/1 h], C-reactive protein (CRP) [7.85(2.37, 22.49) mg/L vs 10.07(3.02, 28.51) mg/L vs 21.28(7.14, 37.74) mg/L] and Bath ankylosing spondylitis functional index (BASFI) [0.70(0.10, 1.30) vs 2.25�
出处 《中华风湿病学杂志》 CSCD 北大核心 2017年第11期732-737,共6页 Chinese Journal of Rheumatology
基金 国家自然科学基金(81571572)
关键词 中轴型脊柱关节炎 疾病活动性 患者总体评价 Axial Spondyloarthritis Disease activity Patient global assessment
  • 相关文献

参考文献4

二级参考文献50

  • 1杨春花,黄烽.高敏C反应蛋白研究进展[J].中华风湿病学杂志,2004,8(12):755-758. 被引量:20
  • 2Claudepierre P, Sibilia J, Roudot-Thoraval F, et al. Factors linked to disease activity in a French cohort of patients with spondyloarthropathy [ J ] . J Rheumatol, 1998, 25 ( 10 ) : 1927- 1931. 被引量:1
  • 3Song IH, Rudwaleit M, Listing J, et al. Comparison of the Bath Ankyiosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations [ J ] . Ann Rheum Dis, 2009, 68 ( 11 ) : 1701-1707. 被引量:1
  • 4Van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features [ J ]. Rheum Dis Clin North Am, 1998, 24 (4) : 663- 776. 被引量:1
  • 5Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis : the Bath Ankylosing Spondylitis Disease Activity Index [ J ]. J Rheumatol, 1994,21 ( 12 ): 2286-2291. 被引量:1
  • 6Jones SD, Calin A, Steiner A. An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices ( BASDAI, BASFI ) : excellent Cronbach's alpha scores [ J ] . J Rheumatol, 1996, 23 (2) : 407. 被引量:1
  • 7Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis [ J ] . J Rheumatol, 1999, 26 (4) : 980-984. 被引量:1
  • 8Sheehan NJ, Slavin BM, Donovan MP, et al.Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis J] .BrJRheumatol, 1986, 25 (2): 171-174. 被引量:1
  • 9Dougados M, Gueguen A, Nakache JP, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis [ J ]. J Rheumatol, 1999, 26 (4) : 971-974. 被引量:1
  • 10Koh WH, Boey ML. Ankylosing spondylitis in Singapore : a study of 150 patients and a local update [ J ] . Ann Acad Med Singapore, 1998, 27 (1):3-6. 被引量:1

共引文献54

同被引文献35

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部